Puma
Trump tax reform uncertainty puts biotech M&A on hold
Richard Staines
Biotech, M&A, Pfizer, Puma, Tesaro
0 Comment
Tesaro and Puma are potential takeover targets
Victory for Puma as FDA approves breast cancer drug
Richard Staines
breast cancer, fda, FDA approvals 2017, Puma, Roche
0 Comment
Neratinib can be used to reduce risk of disease returning.
Puma gains as Roche breast cancer combo disappoints
Richard Staines
asco, ASCO17, breast cancer, cancer, Puma, Roche
0 Comment
ASCO serves up shock as Roche’s data disappoints
FDA advisers back Puma breast cancer drug despite safety worries
Richard Staines
breast cancer, cancer, Puma, R&D, Roche
0 Comment
But biotech still has several hurdles to clear – including Roche’s rival.
Roche breast cancer trial success could kill Puma’s rival
Richard Staines
Biotech, breast cancer, Puma, R&D, Roche
0 Comment
Perjeta trial success sends rival biotech’s share price crashing.